SmofKabiven Per 1000 mL Alanine 7.1 g, arginine 6.1 g, glycine 5.6 g, histidine 1.5 g, isoleucine 2.5 g, leucine 3.8 g, lysine acetate 3.4 g, methionine 2.2 g, phenylalanine 2.6 g, proline 5.7 g, serine 3.3 g, taurine 0.5 g, threonine 2.2 g, tryptophan 1 g, tyrosine 0.2 g, valine 3.1 g, Ca chloride dihydrate 0.28 g, Na glycerophosphate (as hydrate) 2.1 g, Mg sulphate (as heptahydrate) 0.61 g, KCl 2.3 g, Na acetate trihydrate 1.7 g, Zn sulphate (as heptahydrate) 0.0066 g, glucose (as monohydrate) 127 g, soya bean oil (refined) 11.4 g, medium-chain triglycerides 11.4 g, olive oil (refined) 9.5 g, fish oil (rich in omega-3-acids) 5.7 g. SmofKabiven Peripheral Per 1000 mL Glucose (as monohydrate) 71 g, alanine 4.4 g, arginine 3.8 g, glycine 3.5 g, histidine 0.93 g, isoleucine 1.6 g, leucine 2.3 g, lysine acetate 2.1 g, methionine 1.3 g, phenylalanine 1.6 g, proline 3.5 g, serine 2.1 g, taurine 0.32 g, threonine 1.4 g, tryptophan 0.63 g, tyrosine 0.12 g, valine 2 g, Ca chloride dihydrate 0.18 g, Na glycerophosphate (as hydrate) 1.3 g, Mg sulphate (as heptahydrate) 0.38 g, KCl 1.4 g, Na acetate trihydrate 1.1 g, Zn sulphate (as heptahydrate) 0.004 g, soya bean oil (refined) 8.5 g, medium-chain triglycerides 8.5 g, olive oil (refined) 7 g, fish oil (rich in omega-3-acids) 4.2 g
Hypersensitivity to fish, egg, soya or peanut protein. Severe hyperlipidemia, liver insufficiency & blood coagulation disorders; congenital errors of amino acid metabolism; severe renal insufficiency w/o access to hemofiltration or dialysis; acute shock, uncontrolled hyperglycemia; pathologically elevated serum electrolyte levels; acute pulmonary oedema, hyperhydration, decompensated cardiac insufficiency; hemophagocytotic syndrome; unstable conditions eg, severe post-traumatic conditions, uncompensated DM, acute MI, stroke, embolism, metabolic acidosis, severe sepsis, hypotonic dehydration & hyperosmolar coma. Infants & childn <2 yr.
Discontinue use in the presence of anaphylactic shock. Impaired lipid metabolism in renal & hepatic impairment, DM, pancreatitis, hypothyroidism, sepsis. Correct electrolyte & fluid balance disturbances prior to infusion. Predisposition to electrolyte retention. Monitor serum triglycerides, glucose, electrolytes, osmolarity, fluid balance, acid-base status, liver enzyme tests, blood cell count & coagulation. May interfere w/ laboratory measurements (eg, bilirubin, lactose dehydrogenase, oxygen saturation, hemoglobin). Phosphate & K intake should be controlled in patients w/ renal insufficiency. Lactic acidosis, insufficient cellular oxygen supply, increased serum osmolarity; malnourished patients. Increased urinary excretion of the trace elements particularly copper & Zn in IV infusion of amino acids. Hyperglycemia. Do not give w/ blood in the same infusion set. Pregnancy & lactation. Newborn or infant <2 yr.